Showing results (101-110 of 1,059) with videos related to

Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2020
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scalesDavid F Tang-Wai, Eric E Smith, Marie-Andrée Bruneau, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adultsBreno S Diniz, Erica M Vieira, Ana Paula Mendes-Silva, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
The Cognitive & Leisure Activity Scale (CLAS): A new measure to quantify cognitive activities in older adults with and without cognitive impairmentJames E Galvin, Magdalena I Tolea, Stephanie Chrisphonte
Alzheimer'S & Dementia (New York, N. Y.)|March 29, 2021
Plan switching among Medicare Advantage beneficiaries with Alzheimer's disease and other dementiasDavid J Meyers, Momotazur Rahman, Maricruz Rivera-Hernandez, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 29, 2021
Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's diseaseHuntington Potter, Jonathan H Woodcock, Timothy D Boyd, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
Amyloid beta cleavage by ANA-TA9, a synthetic peptide from the ANA/BTG3 Box A regionYusuke Hatakawa, Rina Nakamura, Motomi Konishi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trialsKathy Y Liu, Anya Borissova, Jansher Mahmood, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 3, 2022
Erratum
Alzheimer'S & Dementia (New York, N. Y.)|December 6, 2023
Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairmentCaterina Padulo, Carlo Sestieri, Miriam Punzi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 13, 2023
Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β productionAyesha Khan, Richard Killick, Daniel Wirth, et al.
Pageof 106